News

Dr. Kim Chi, medical oncologist and clinician-scientist with BC Cancer, has been named a highly cited researcher in 2025 by Clarivate, a global organization that analyzes academic publications, citations and research impact.

“This recognition reflects my career-long commitment to improving care for people with prostate cancer,” says Dr. Kim Chi, medical oncologist, BC Cancer. “Our research has always been driven by the needs of patients, and this honour highlights the collective efforts of our collaborators, co-investigators and dedicated staff who make this work possible.”

Pictured above is Dr. Huntsman in St. Johns Newfoundland, near the place where Terry Fox began his run.

A new study from BC Cancer researchers explores how to better support oncology nurses in engaging patients and families in advance care planning (ACP).

Dr. Christian Steidl, senior scientist and Executive Director, Research at BC Cancer, is the recipient of a 2025 Operating Grant in Blood Cancer, co-funded by AstraZeneca Canada and the Leukemia & Lymphoma Society of Canada.

The research is dedicated to developing innovative tools for precise and efficient gene editing in B-cell lymphomas. By targeting the underlying genetic causes of cancer, this work paves the way for novel treatment strategies and opens new possibilities for patients living with B-cell lymphoma.

BC Cancer senior scientist, Dr. Alexander Wyatt, has been appointed the UBC President’s Excellence Chair in Precision Oncology by the UBC Faculty of Medicine. 

With renewed support from a $5.5-million Terry Fox New Frontiers Program Project Grant, leading researchers from BC Cancer and the University of British Columbia (UBC) are determined to change how we understand and treat sarcomas – rare and aggressive bone and soft tissue cancers that disproportionately affect young people.